The European Union’s drug regulatory agency on Thursday recommended Pfizer-BioNTech COVID-19 Vaccine for Children 5 to 11 Years Old.
Running news: The European Medicines Agency said the dosage for children “will be lower than the dose used in people 12 years of age and older,” according to a press release from the agency.
- He cited a study in children aged 5 to 11 that found the vaccine to be 90.7% effective in preventing symptomatic COVID-19.
- The recommendation will be sent to the European Commission, which will issue a final decision.
big picture: The announcement comes after the CDC recommended Pfizer shots for children in the same age group earlier this month.
what to watch: Pfizer and BioNTech said that they have submitted Request for authorization of their COVID-19 vaccine for children to other regulators around the world.
- The companies say they also expect early critical data from ongoing clinical trials in children aged 2 to 5 years this quarter and 6 months to 2 years of age in the first quarter of 2022.